Literature DB >> 18544202

Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil.

V Saraceni1, B S King, S C Cavalcante, J E Golub, L M Lauria, L H Moulton, R E Chaisson, B Durovni.   

Abstract

SETTING: Data from the mortality database, Rio de Janeiro City (RJC) Health Department, Rio de Janeiro, Brazil.
OBJECTIVES: To determine the role played by tuberculosis (TB) in Brazil's human immunodeficiency virus (HIV) positive population, we investigated the frequency of TB as the primary cause of death among HIV-positive subjects in RJC.
DESIGN: Information about acquired immune-deficiency syndrome (AIDS) deaths from 1996 to 2005 in individuals aged >12 years was obtained from the Mortality Information System (SIM), and the cause of death was classified according to the International Classification of Diseases (ICD-10), through primary causes coded in Chapter I--B20 to B24 (HIV disease).
RESULTS: There were 8601 AIDS-related deaths in RJC between 1996 and 2005. TB was the primary cause of death in 9.0% of all AIDS-related deaths, while Pneumocystis carinii pneumonia (PCP) accounted for 4.7%. TB cases erroneously classified under other infectious diseases may have contributed to an underestimation of the number of TB deaths among HIV-positive patients.
CONCLUSION: Our study showed that TB is the leading cause of AIDS-related deaths and is responsible for twice as many deaths as PCP, in a scenario of free access to antiretrovirals. The potential benefits of TB preventive treatment and of the availability of highly active antiretroviral treatment could not be established by this analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544202      PMCID: PMC3731736     

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

1.  [Reclink: an application for database linkage implementing the probabilistic record linkage method].

Authors:  K R Camargo; C M Coeli
Journal:  Cad Saude Publica       Date:  2000 Apr-Jun       Impact factor: 1.632

2.  Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Authors:  Nancy F Crum; Robert H Riffenburgh; Scott Wegner; Brian K Agan; Sybil A Tasker; Katherine M Spooner; Adam W Armstrong; Susan Fraser; Mark R Wallace
Journal:  J Acquir Immune Defic Syndr       Date:  2006-02-01       Impact factor: 3.731

3.  Identifying deaths from AIDS in South Africa.

Authors:  Pam Groenewald; Nadine Nannan; David Bourne; Ria Laubscher; Debbie Bradshaw
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

4.  Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

Authors:  Charlotte Lewden; Dominique Salmon; Philippe Morlat; Sibylle Bévilacqua; Eric Jougla; Fabrice Bonnet; Laurence Héripret; Dominique Costagliola; Thierry May; Geneviève Chêne
Journal:  Int J Epidemiol       Date:  2004-11-23       Impact factor: 7.196

5.  Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy.

Authors:  Valéria Saraceni; Marly Marques da Cruz; Lilian de Mello Lauria; Betina Durovni
Journal:  Braz J Infect Dis       Date:  2005-10-03       Impact factor: 1.949

6.  Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Authors:  Kholoud Porter; Abdel Babiker; Krishnan Bhaskaran; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; A Sarah Walker
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

Review 7.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12

8.  The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.

Authors:  Jonathan E Golub; Valeria Saraceni; Solange C Cavalcante; Antonio G Pacheco; Lawrence H Moulton; Bonnie S King; Anne Efron; Richard D Moore; Richard E Chaisson; Betina Durovni
Journal:  AIDS       Date:  2007-07-11       Impact factor: 4.177

9.  Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.

Authors:  Colette Smit; Ronald Geskus; Sarah Walker; Caroline Sabin; Roel Coutinho; Kholoud Porter; Maria Prins
Journal:  AIDS       Date:  2006-03-21       Impact factor: 4.177

  9 in total
  19 in total

1.  Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.

Authors:  Salome Charalambous; Alison D Grant; Craig Innes; Christopher J Hoffmann; Rob Dowdeswell; Jan Pienaar; Katherine L Fielding; Gavin J Churchyard
Journal:  AIDS       Date:  2010-11       Impact factor: 4.177

2.  The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.

Authors:  Betina Durovni; Solange C Cavalcante; Valeria Saraceni; Vitoria Vellozo; Giselle Israel; Bonnie S King; Silvia Cohn; Anne Efron; Antonio G Pacheco; Lawrence H Moulton; Richard E Chaisson; Jonathan E Golub
Journal:  AIDS       Date:  2010-11       Impact factor: 4.177

3.  Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific.

Authors:  D Rupasinghe; S Kiertiburanakul; A Kamarulzaman; F Zhang; N Kumarasamy; R Chaiwarith; T P Merati; C D Do; S Khusuwan; A Avihingsanon; M P Lee; P S Ly; E Yunihastuti; K V Nguyen; R Ditangco; Y J Chan; S Pujari; O T Ng; J Y Choi; Blh Sim; J Tanuma; S Sangle; J Ross; M Law
Journal:  HIV Med       Date:  2019-12-18       Impact factor: 3.180

4.  Early mortality and cause of deaths in patients using HAART in Brazil and the United States.

Authors:  Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

5.  Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.

Authors:  Valeria Saraceni; Silvia Cohn; Solange C Cavalcante; Antonio G F Pacheco; Lawrence H Moulton; Richard E Chaisson; Betina Durovni; Jonathan E Golub
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

6.  The reduction of tuberculosis risks by smoking cessation.

Authors:  Chi-Pang Wen; Ta-Chien Chan; Hui-Ting Chan; Min-Kuang Tsai; Ting-Yuang Cheng; Shan-Pou Tsai
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

Review 7.  Epidemiology of HIV-associated tuberculosis.

Authors:  Stephen D Lawn; Gavin Churchyard
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

8.  Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

Authors:  Jonathan E Golub; Paul Pronyk; Lerato Mohapi; Nkeko Thsabangu; Mosa Moshabela; Helen Struthers; Glenda E Gray; James A McIntyre; Richard E Chaisson; Neil A Martinson
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177

9.  Improving indicators of tuberculosis program cascades by leveraging HIV program strategies.

Authors:  S C Meribe; E Harausz; I Lawal; A Ogundeji; C Mbanefo; Y Adamu; N A Hussain; L Chittenden; R Nelson
Journal:  Public Health Action       Date:  2019-12-21

10.  Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand.

Authors:  Pacharee Kantipong; Kuniko Murakami; Saiyud Moolphate; Myo Nyein Aung; Norio Yamada
Journal:  HIV AIDS (Auckl)       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.